Literature DB >> 18299331

Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.

Hironao Wakabayashi1, Philip J Fay.   

Abstract

Factor VIII circulates as a heterodimer composed of heavy (A1A2B domains) and light (A3C1C2 domains) chains, whereas the contiguous A1A2 domains are separate subunits in the active cofactor, factor VIIIa. Whereas the A1 subunit maintains a stable interaction with the A3C1C2 subunit, the A2 subunit is weakly associated in factor VIIIa and its dissociation accounts for the labile activity of the cofactor. In examining the ceruloplasmin-based factor VIII A domain model, potential hydrogen bonding based upon spatial separations of <2.8A were found between side chains of 14 A2 domain residues and 7 and 9 residues in the A1 and A3 domains, respectively. These residues were individually replaced with Ala, except Tyr residues were replaced with Phe, and proteins stably expressed to examine the contribution of each residue to protein stability. Factor VIII stability at 55 degrees C and factor VIIIa activity were monitored using factor Xa generation assays. Fourteen of 30 factor VIII mutants showed >2-fold increases in either or both decay rates compared with wild type; whereas, 7 mutants showed >2-fold increased rates in factor VIIIa decay compared with factor VIII decay. These results suggested that multiple residues at the A1-A2 and A2-A3 domain interfaces contribute to stabilizing the protein. Furthermore, these data discriminate residues that stabilize interactions in the procofactor from those in the cofactor, where hydrogen bonding in the latter appears to contribute more significantly to stability. This observation is consistent with an altered conformation involving new inter-subunit interactions involving A2 domain following procofactor activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299331      PMCID: PMC2431055          DOI: 10.1074/jbc.M710252200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Altered interactions between the A1 and A2 subunits of factor VIIIa following cleavage of A1 subunit by factor Xa.

Authors:  Keiji Nogami; Hironao Wakabayashi; Kyla Schmidt; Philip J Fay
Journal:  J Biol Chem       Date:  2002-11-07       Impact factor: 5.157

2.  Ca(2+) binding to both the heavy and light chains of factor VIII is required for cofactor activity.

Authors:  Hironao Wakabayashi; Kyla M Schmidt; Philip J Fay
Journal:  Biochemistry       Date:  2002-07-02       Impact factor: 3.162

Review 3.  Activation of factor VIII and mechanisms of cofactor action.

Authors:  Philip J Fay
Journal:  Blood Rev       Date:  2004-03       Impact factor: 8.250

4.  Residues 110-126 in the A1 domain of factor VIII contain a Ca2+ binding site required for cofactor activity.

Authors:  Hironao Wakabayashi; Jan Freas; Qian Zhou; Philip J Fay
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

5.  Methodology of the one-stage assay of Factor VIII (VIII:C).

Authors:  J Over
Journal:  Scand J Haematol Suppl       Date:  1984

6.  Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid.

Authors:  P Lollar; G J Knutson; D N Fass
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

7.  Metal ion-independent association of factor VIII subunits and the roles of calcium and copper ions for cofactor activity and inter-subunit affinity.

Authors:  H Wakabayashi; M E Koszelak; M Mastri; P J Fay
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

8.  pH-dependent denaturation of thrombin-activated porcine factor VIII.

Authors:  P Lollar; C G Parker
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

9.  Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit.

Authors:  P J Fay; P J Haidaris; T M Smudzin
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

10.  Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside.

Authors:  L T Mimms; G Zampighi; Y Nozaki; C Tanford; J A Reynolds
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

View more
  19 in total

1.  Mutation analysis of factor VIII in Korean patients with severe hemophilia A.

Authors:  Chur-Woo You; Hee-Sook Son; Hee Jin Kim; Eui-Jeon Woo; Soon-Ae Kim; Haing-Woon Baik
Journal:  Int J Hematol       Date:  2010-06-10       Impact factor: 2.490

2.  Role of hydrophobic mutations on the binding affinity and stability of blood coagulation factor VIIIa: a computational molecular dynamics and free-energy analysis.

Authors:  Divi Venkateswarlu
Journal:  Biochem Biophys Res Commun       Date:  2014-06-18       Impact factor: 3.575

3.  Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  Biochemistry       Date:  2013-05-21       Impact factor: 3.162

4.  Mass spectrometry-assisted study reveals that lysine residues 1967 and 1968 have opposite contribution to stability of activated factor VIII.

Authors:  Esther Bloem; Henriet Meems; Maartje van den Biggelaar; Carmen van der Zwaan; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

5.  Enhancing factor VIII and VIIIa stability by combining mutations at the A2 domain interface and A1-C2 domain interface.

Authors:  H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

6.  Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.

Authors:  M Monaghan; H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2016-03-21       Impact factor: 5.824

7.  Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stability.

Authors:  Hironao Wakabayashi; Amy E Griffiths; Philip J Fay
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

8.  Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

Authors:  Matthew P Kosloski; Krithika A Shetty; Hironao Wakabayashi; Philip J Fay; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2014-06-17       Impact factor: 4.009

9.  Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.

Authors:  Divi Venkateswarlu
Journal:  BMC Struct Biol       Date:  2010-02-25

10.  Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface.

Authors:  Hironao Wakabayashi; Fatbardha Varfaj; Jennifer Deangelis; Philip J Fay
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.